Jump to content

ADCYAP1R1

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 16:23, 23 July 2011 (→‎Further reading: doi= 10.1016/S0167-0115(02)00003-4). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:PBB Pituitary adenylate cyclase-activating polypeptide type I receptor also known as PAC1, is a protein that in humans is encoded by the ADCYAP1R1 gene.[1] This receptor binds pituitary adenylate cyclase activating peptide.[2][3]

PAC1 is a membrane-associated protein and shares significant homology with members of the G-protein coupled class B glucagon/secretin receptor family. This receptor mediates diverse biological actions of adenylate cyclase activating polypeptide 1 and is positively coupled to adenylate cyclase. Alternative splicing of two exons of this gene generates four major splice variants, but their full-length nature has not been determined.[1] PAC1 is expressed in the adrenal medulla, pancreatic acini, uterus, myenteric plexus and brain.[4][5][6] It is also expressed in the trigeminal, otic and superior cervical ganglia (prejunctional) and cerebral arteries (postjunctional).[7]

References

  1. ^ a b "Entrez Gene: ADCYAP1R1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I".
  2. ^ Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M (1993). "Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor". Biochem. Biophys. Res. Commun. 196 (3): 1511–21. doi:10.1006/bbrc.1993.2423. PMID 7902709.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H (2000). "Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions". Pharmacol. Rev. 52 (2): 269–324. PMID 10835102.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Reubi JC (2000). "In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications". Ann N Y Acad Sci. 921: 11193811. doi:10.1111/j.1749-6632.2000.tb06946.x. PMID 11193811.
  5. ^ Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P and Laissue JA. (2000). "Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin". Cancer Res. 60 (11): 3105–3112. PMID 10850463.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Vaudry H and Gallo-Payet N. (1998). "Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation". J Clin Endocrinol Metab. 83 (4): 1299–1305. doi:10.1210/jc.83.4.1299. PMID 9543159.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Knutsson, M.; Edvinsson, L. (2002). "Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia". Neuroreport. 13 (4): 507–9. doi:10.1097/00001756-200203250-00030. PMID 11930171. {{cite journal}}: Unknown parameter |month= ignored (help)

Further reading

  • Stoffel M, Espinosa R, Trabb JB; et al. (1995). "Human type I pituitary adenylate cyclase activating polypeptide receptor (ADCYAP1R): localization to chromosome band 7p14 and integration into the cytogenetic, physical, and genetic map of chromosome 7". Genomics. 23 (3): 697–9. doi:10.1006/geno.1994.1560. PMID 7851900. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Ogi K, Miyamoto Y, Masuda Y; et al. (1994). "Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor". Biochem. Biophys. Res. Commun. 196 (3): 1511–21. doi:10.1006/bbrc.1993.2423. PMID 7902709. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Ohtaki T, Masuda Y, Ishibashi Y; et al. (1994). "Purification and characterization of the receptor for pituitary adenylate cyclase-activating polypeptide". J. Biol. Chem. 268 (35): 26650–7. PMID 8253796. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Pisegna JR, Wank SA (1996). "Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C.". J. Biol. Chem. 271 (29): 17267–74. doi:10.1074/jbc.271.29.17267. PMID 8663363.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  • Pantaloni C, Brabet P, Bilanges B; et al. (1996). "Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation". J. Biol. Chem. 271 (36): 22146–51. doi:10.1074/jbc.271.36.22146. PMID 8703026. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  • Solano RM, Carmena MJ, Carrero I; et al. (1996). "Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate". Endocrinology. 137 (7): 2815–22. doi:10.1210/en.137.7.2815. PMID 8770902. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Wei Y, Mojsov S (1997). "Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology". J. Neuroendocrinol. 8 (11): 811–7. doi:10.1046/j.1365-2826.1996.05191.x. PMID 8933357.
  • Brabet P, Diriong S, Journot L; et al. (1997). "Localization of the human pituitary adenylate cyclase-activating polypeptide receptor (PACAP1-R) gene to 7p15-p14 by fluorescence in situ hybridization". Genomics. 38 (1): 100–2. doi:10.1006/geno.1996.0600. PMID 8954788. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Yon L, Breault L, Contesse V; et al. (1998). "Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation". J. Clin. Endocrinol. Metab. 83 (4): 1299–305. doi:10.1210/jc.83.4.1299. PMID 9543159. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Steinhoff M, McGregor GP, Radleff-Schlimme A; et al. (1999). "Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis". Regul. Pept. 80 (1–2): 49–55. doi:10.1016/S0167-0115(99)00010-5. PMID 10235634. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Zeng N, Athmann C, Kang T; et al. (1999). "PACAP type I receptor activation regulates ECL cells and gastric acid secretion". J. Clin. Invest. 104 (10): 1383–91. doi:10.1172/JCI7537. PMC 409843. PMID 10562300. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Dautzenberg FM, Mevenkamp G, Wille S, Hauger RL (2000). "N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants". J. Neuroendocrinol. 11 (12): 941–9. doi:10.1046/j.1365-2826.1999.00411.x. PMID 10583729.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Scaldaferri ML, Modesti A, Palumbo C; et al. (2000). "Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta". Endocrinology. 141 (3): 1158–67. doi:10.1210/en.141.3.1158. PMID 10698193. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Busto R, Prieto JC, Bodega G; et al. (2000). "Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung". Peptides. 21 (2): 265–9. doi:10.1016/S0196-9781(99)00202-8. PMID 10764955. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Knutsson M, Edvinsson L (2002). "Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia". Neuroreport. 13 (4): 507–9. doi:10.1097/00001756-200203250-00030. PMID 11930171.
  • Miampamba M, Germano PM, Arli S; et al. (2002). "Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons". Regul. Pept. 105 (3): 145–54. doi:10.1016/S0167-0115(02)00003-4. PMID 11959368. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Le SV, Yamaguchi DJ, McArdle CA; et al. (2003). "PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells". Regul. Pept. 109 (1–3): 115–25. doi:10.1016/S0167-0115(02)00194-5. PMID 12409223. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Ronaldson E, Robertson DN, Johnson MS; et al. (2003). "Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF". Regul. Pept. 109 (1–3): 193–8. doi:10.1016/S0167-0115(02)00204-5. PMID 12409233. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Isobe K, Tatsuno I, Yashiro T; et al. (2003). "Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis". Regul. Pept. 110 (3): 213–7. doi:10.1016/S0167-0115(02)00209-4. PMID 12573802. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

This article incorporates text from the United States National Library of Medicine, which is in the public domain.



Stub icon

This membrane protein–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=ADCYAP1R1&oldid=441020603"